Sequenom, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Non-Invasive Preeclampsia Screening and Biobank
- Conditions
- Preeclampsia (PE)
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 6550
- Registration Number
- NCT06643741
- Locations
- 🇺🇸
UT Health, Houston, Texas, United States
🇺🇸Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸St. David's Women's Center of Texas, Austin, Texas, United States
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
- Conditions
- Influenza ARSV InfectionCOVID-19 Respiratory InfectionInfluenza Type B
- Interventions
- Device: Labcorp COVID-19+Flu+RSV Test Home Collection Kit
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 990
- Registration Number
- NCT06008457
- Locations
- 🇺🇸
Exer Urgent Care, Pasadena, California, United States
Development of a NIPTT for Detecting Copy Number Variations
- Conditions
- Copy Number Variations
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT04774640
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- Conditions
- Pregnancy
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 25000
- Registration Number
- NCT04595201
- Locations
- 🇺🇸
Integrated Genetics, Westborough, Massachusetts, United States
Compliant Analysis of Patient Samples and Data
- Conditions
- Pregnancy RelatedInfectious DiseaseCancer
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT04364503
- Locations
- 🇺🇸
Sequenom, Inc, San Diego, California, United States
Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test
- Conditions
- Rheumatoid Arthritis
- Interventions
- Genetic: Vectra MBDA Test
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 444
- Registration Number
- NCT03810144
- Locations
- 🇺🇸
MedStar Shah Medical Group, Hollywood, Maryland, United States
🇺🇸The Center for Rheumatology and Bone Research, Wheaton, Maryland, United States
🇺🇸Klein & Associates, Hagerstown, Maryland, United States
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis (RA)
- Interventions
- Diagnostic Test: Vectra
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT03631225
- Locations
- 🇺🇸
AARDS Research, Inc., Aventura, Florida, United States
🇺🇸Robert W. Levin, MD, PA, Clearwater, Florida, United States
🇺🇸North Mississippi Medical Center, Tupelo, Mississippi, United States
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
- Conditions
- Non-hematologic Cancer
- First Posted Date
- 2015-10-26
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 3000
- Registration Number
- NCT02586389
- Locations
- 🇺🇸
Idaho Urology, Boise, Idaho, United States
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
- Conditions
- Turner SyndromeDown SyndromeEdwards SyndromePatau Syndrome
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2015-09-17
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02226315
- Locations
- 🇺🇸
Presbyterian/St. Luke's Medical Center, Denver, Colorado, United States
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
- Conditions
- Age Related Macular DegenerationCentral Serous ChorioretinopathyChoroidal Neovascularization
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2015-09-18
- Lead Sponsor
- Sequenom, Inc.
- Target Recruit Count
- 152
- Registration Number
- NCT01880788
- Locations
- 🇺🇸
Vitreous Retina Macula Consultants of New York, New York City, New York, United States